FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation. The FDA recently shifted several peptides off the Category 2 safety risk list tied to compounding rules. First, that FDA Compliance for Peptide Therapy and BPC 157 Holt Law